myirislogo
18 December, 2014 19:51 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 307.05 1.66
Ntpc 132.95 3.83
Hindalco In 153.60 4.31
Tata Stl 401.85 2.13
Sslt 203.75 1.44
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Wintac Limited
Wintac Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:524758NSE:NABloomberg:RCN@INReuters:RECO.BO
Market Lot: 1Face Value: 10ISIN Demat: INE812C01016
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
02-MAY-14 Wintac announced that the company has received the US FDA approval for the manufacturing plant (manufacture of pharmaceutical formulations - sterile injections and ophthalmic products) at Nelamangala, Bangalore. 23-APR-10 Wintac announced that it has received formal approval for the ANDA from US FDA authorities for Ondansetron Hydrochloride 20 ml Injection. 03-DEC-09 Wintac today announced that its manufacturing plant at Nelamangal...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Wintac surges on USFDA nod for Bangalore plant  -IRIS 05-May-14
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)
Net sales
Other Income
Total Income
Cost of goods sold
OPBDIT
PAT
Gross Block
Equity capital
EPS (Rs.)
DPS (Rs.)
BV (Rs.)
P/E range (x)
Debt / Equity (x)
Operating margin (% of OI)
Net margin (% of OI)
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
Not Available
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer